Sandoz recalls China-made blood pressure drug

Nov 12, 2018

Novartis said its Sandoz division is recalling one lot of losartan tablets after finding traces of a probable carcinogen in the blood pressure drug.

The recall is due to a small amount of the impurity, N-nitrosodiethylamine, found in the API Losartan. The drug is made by China’s Zhejiang Huahai Pharmaceutical, which was placed under high supervision last month by the EMA after a probable carcinogen was found in its blood pressure drug, valsartan.

No adverse events have been reported but Novartis is notifying its distributors by letter via overnight mail and patients by public notification.

Read the press release

Want to get news like this in your inbox?  Subscribe to our eNewsletter here!

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments